Company Reports Q1 Revenue of RMB 1.24B, Up 64%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Reports Q1 revenue RMB1.24B, up 64% from RMB753.7M last year. CEO Peng Shen commented: "We opened the year with a solid first-quarter result, underpinned by rapid top-line growth. As we look to the future, we remain dedicated to the enduring purpose that has shaped our journey since day one. In 2026, we aim to move faster toward becoming an AI-native company to strengthen execution and support durable value for our users and shareholders."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WDH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WDH
About WDH
Waterdrop Inc is a holding company principally engaged in the provision of insurance and healthcare service. The Company mainly operates through three segments. The Insurance segment is primarily engaged in the provision of insurance brokerage service, such as health and life insurance products, as well as technical service. The Crowdfunding segment is primarily engaged in the provision of crowdfunding service. The Others segment include online sale of health products, and the provision of digital multichannel marketing solution and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Waterdrop Inc Reports 64.8% Revenue Growth in Q1 2026
- Significant Revenue Growth: Waterdrop Inc reported Q1 2026 revenue of RMB 1.24 billion, reflecting a 64.8% year-over-year increase, indicating strong market performance, particularly driven by its insurance segment, which enhances its competitive position.
- Robust Insurance Segment: The insurance business generated RMB 1.15 billion in income, up 74.1% year-over-year, driven by effective user acquisition strategies and traffic investments, showcasing the company's ongoing growth potential in the insurance sector.
- AI Technology Adoption: The company has filed 75 patent applications related to large language models, indicating its accelerated shift towards becoming an AI-native company, which is expected to enhance operational efficiency and drive future revenue growth.
- Continued Shareholder Returns: Waterdrop completed its fifth cash dividend since its IPO, distributing approximately $10.8 million to shareholders, demonstrating its commitment to returning value to investors while maintaining a strong cash reserve.
See More
Waterdrop Inc. Reports Strong Q1 2026 Financial Results
- Significant Revenue Growth: In Q1 2026, Waterdrop Inc. achieved net operating revenue of RMB 1.242 billion, representing a 64.8% year-over-year increase, indicating sustained market demand in the insurance and healthcare sectors and laying a solid foundation for the next decade.
- Consistent Profitability: The company reported a net profit of RMB 98.4 million, marking its 17th consecutive quarter of profitability, which demonstrates the stability and sustainability of its business model, thereby enhancing investor confidence.
- Strong Insurance Business: Insurance-related income grew 74.1% year-over-year, with first-year premiums facilitated by the
See More
Waterdrop Inc. Reports Strong Q1 2026 Financial Results
- Insurance Business Growth: Waterdrop's insurance-related income surged 74.1% year-over-year in Q1 2026, reflecting the company's ongoing investments in user acquisition and traffic infrastructure, which are expected to enhance its competitive position in the market.
- New Product Launch: The company introduced the 'Shouhu Ruchu' cancer insurance plan with metastasis coverage and optional recurrence benefits, achieving a 24.3% year-over-year increase in premiums for pre-existing condition insurance, aiming to broaden accessibility to insurance.
- Digital Clinical Trial Progress: The E-Find platform partnered with 243 pharmaceutical companies in Q1, enrolling 957 patients, with revenue from digital clinical trial solutions reaching approximately RMB 24.2 million, up 5.4% year-over-year, indicating strong growth potential in innovative drug trials.
- Share Repurchase Program: As of May 31, 2026, the company repurchased approximately 61.8 million ADSs for about $120.1 million and paid a cash dividend of approximately $10.8 million, demonstrating its commitment to delivering long-term value to shareholders.
See More
Waterdrop Inc. Reports Strong Q1 2026 Financial Results
- Core Business Growth: In Q1 2026, Waterdrop Inc. reported net operating revenue of RMB 1,242.2 million (approximately USD 180.1 million), reflecting a robust year-over-year increase of 64.8%, indicating strong market demand and business expansion capabilities.
- Insurance Revenue Surge: Insurance-related income reached RMB 1,145.8 million (approximately USD 166.1 million), marking a 74.1% year-over-year growth, showcasing the company's competitive edge in the insurance market and the effectiveness of its technical services.
- Crowdfunding Platform Expansion: As of March 31, 2026, the Waterdrop Medical Crowdfunding platform has attracted approximately 494 million donors, raising a total of RMB 73.5 billion to support 3.75 million patients, further solidifying its leadership position in the medical crowdfunding sector.
- Shareholder Return Program: As of May 31, 2026, the company repurchased approximately 61.8 million ADSs for about USD 120.1 million and paid a cash dividend of approximately USD 10.8 million, demonstrating a strong commitment to shareholder returns.
See More
Waterdrop Q1 Earnings: Revenue Up 64.8% Year-over-Year
- Significant Revenue Growth: Waterdrop reported Q1 revenue of RMB 180.09 million, reflecting a robust year-over-year increase of 64.8%, which underscores the company's strong growth potential in the medical crowdfunding sector and solidifies its market position.
- Insurance-Related Income Surge: The quarter saw insurance-related income reach RMB 1,145.8 million (approximately $166.1 million), marking a 74.1% increase from the same period in 2025, indicating successful promotion of insurance products and enhancing financial stability.
- Patient Donation Impact: As of March 31, 2026, approximately 494 million individuals have cumulatively donated RMB 73.5 billion to 3.75 million patients, highlighting the company's positive social impact and user engagement, which enhances its brand image.
- Clinical Trial Participation: By March 31, 2026, the company had enrolled 15,512 patients in 1,718 clinical trial programs through the E-Find platform, demonstrating its commitment to innovation and contribution to medical research.
See More
Waterdrop to Report Q1 Financial Results on June 16, 2026
- Earnings Report Schedule: Waterdrop Inc. will release its unaudited financial results for the first quarter ended March 31, 2026, before U.S. markets open on June 16, 2026, indicating the company's ongoing growth in the insurance and healthcare sectors.
- Conference Call Details: The management team will hold a conference call at 8:00 AM U.S. Eastern Time on the same day to discuss the financial results, emphasizing the company's commitment to transparency and investor communication by encouraging participants to dial in 15 minutes early.
- Multilingual Support: The conference call will offer both Chinese and English interpretation options, reflecting the company's focus on catering to a diverse investor base and enhancing accessibility.
- Webcast and Replay Availability: Telephone replays will be accessible two hours after the call concludes, and live as well as archived webcasts will be available on the company's investor relations website, thereby increasing investor engagement and awareness of company developments.
See More
Waterdrop Inc Reports 64.8% Revenue Growth in Q1 2026
- Significant Revenue Growth: Waterdrop Inc reported Q1 2026 revenue of RMB 1.24 billion, reflecting a 64.8% year-over-year increase, indicating strong market performance, particularly driven by its insurance segment, which enhances its competitive position.
- Robust Insurance Segment: The insurance business generated RMB 1.15 billion in income, up 74.1% year-over-year, driven by effective user acquisition strategies and traffic investments, showcasing the company's ongoing growth potential in the insurance sector.
- AI Technology Adoption: The company has filed 75 patent applications related to large language models, indicating its accelerated shift towards becoming an AI-native company, which is expected to enhance operational efficiency and drive future revenue growth.
- Continued Shareholder Returns: Waterdrop completed its fifth cash dividend since its IPO, distributing approximately $10.8 million to shareholders, demonstrating its commitment to returning value to investors while maintaining a strong cash reserve.
See More
Waterdrop Inc. Reports Strong Q1 2026 Financial Results
- Significant Revenue Growth: In Q1 2026, Waterdrop Inc. achieved net operating revenue of RMB 1.242 billion, representing a 64.8% year-over-year increase, indicating sustained market demand in the insurance and healthcare sectors and laying a solid foundation for the next decade.
- Consistent Profitability: The company reported a net profit of RMB 98.4 million, marking its 17th consecutive quarter of profitability, which demonstrates the stability and sustainability of its business model, thereby enhancing investor confidence.
- Strong Insurance Business: Insurance-related income grew 74.1% year-over-year, with first-year premiums facilitated by the
See More
Waterdrop Inc. Reports Strong Q1 2026 Financial Results
- Insurance Business Growth: Waterdrop's insurance-related income surged 74.1% year-over-year in Q1 2026, reflecting the company's ongoing investments in user acquisition and traffic infrastructure, which are expected to enhance its competitive position in the market.
- New Product Launch: The company introduced the 'Shouhu Ruchu' cancer insurance plan with metastasis coverage and optional recurrence benefits, achieving a 24.3% year-over-year increase in premiums for pre-existing condition insurance, aiming to broaden accessibility to insurance.
- Digital Clinical Trial Progress: The E-Find platform partnered with 243 pharmaceutical companies in Q1, enrolling 957 patients, with revenue from digital clinical trial solutions reaching approximately RMB 24.2 million, up 5.4% year-over-year, indicating strong growth potential in innovative drug trials.
- Share Repurchase Program: As of May 31, 2026, the company repurchased approximately 61.8 million ADSs for about $120.1 million and paid a cash dividend of approximately $10.8 million, demonstrating its commitment to delivering long-term value to shareholders.
See More
Waterdrop Inc. Reports Strong Q1 2026 Financial Results
- Core Business Growth: In Q1 2026, Waterdrop Inc. reported net operating revenue of RMB 1,242.2 million (approximately USD 180.1 million), reflecting a robust year-over-year increase of 64.8%, indicating strong market demand and business expansion capabilities.
- Insurance Revenue Surge: Insurance-related income reached RMB 1,145.8 million (approximately USD 166.1 million), marking a 74.1% year-over-year growth, showcasing the company's competitive edge in the insurance market and the effectiveness of its technical services.
- Crowdfunding Platform Expansion: As of March 31, 2026, the Waterdrop Medical Crowdfunding platform has attracted approximately 494 million donors, raising a total of RMB 73.5 billion to support 3.75 million patients, further solidifying its leadership position in the medical crowdfunding sector.
- Shareholder Return Program: As of May 31, 2026, the company repurchased approximately 61.8 million ADSs for about USD 120.1 million and paid a cash dividend of approximately USD 10.8 million, demonstrating a strong commitment to shareholder returns.
See More
Waterdrop Q1 Earnings: Revenue Up 64.8% Year-over-Year
- Significant Revenue Growth: Waterdrop reported Q1 revenue of RMB 180.09 million, reflecting a robust year-over-year increase of 64.8%, which underscores the company's strong growth potential in the medical crowdfunding sector and solidifies its market position.
- Insurance-Related Income Surge: The quarter saw insurance-related income reach RMB 1,145.8 million (approximately $166.1 million), marking a 74.1% increase from the same period in 2025, indicating successful promotion of insurance products and enhancing financial stability.
- Patient Donation Impact: As of March 31, 2026, approximately 494 million individuals have cumulatively donated RMB 73.5 billion to 3.75 million patients, highlighting the company's positive social impact and user engagement, which enhances its brand image.
- Clinical Trial Participation: By March 31, 2026, the company had enrolled 15,512 patients in 1,718 clinical trial programs through the E-Find platform, demonstrating its commitment to innovation and contribution to medical research.
See More
Waterdrop to Report Q1 Financial Results on June 16, 2026
- Earnings Report Schedule: Waterdrop Inc. will release its unaudited financial results for the first quarter ended March 31, 2026, before U.S. markets open on June 16, 2026, indicating the company's ongoing growth in the insurance and healthcare sectors.
- Conference Call Details: The management team will hold a conference call at 8:00 AM U.S. Eastern Time on the same day to discuss the financial results, emphasizing the company's commitment to transparency and investor communication by encouraging participants to dial in 15 minutes early.
- Multilingual Support: The conference call will offer both Chinese and English interpretation options, reflecting the company's focus on catering to a diverse investor base and enhancing accessibility.
- Webcast and Replay Availability: Telephone replays will be accessible two hours after the call concludes, and live as well as archived webcasts will be available on the company's investor relations website, thereby increasing investor engagement and awareness of company developments.
See More
